Journal article
HPV vaccination of immunocompromised hosts
SM Garland, JML Brotherton, AB Moscicki, AM Kaufmann, M Stanley, N Bhatla, R Sankaranarayanan, S de Sanjose, JM Palefsky
PAPILLOMAVIRUS RESEARCH | ELSEVIER SCIENCE BV | Published : 2017
Abstract
It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly recommended that vaccination occur according to national guidelines. When delivered to immunocompromised populations, HPV vaccines should be given as a 3-dose regimen.
Grants
Awarded by World Health Organization